Development of cellular signaling pathway inhibitors as new antivirals against influenza.
Planz, Oliver
Development of cellular signaling pathway inhibitors as new antivirals against influenza. [electronic resource] - Antiviral research Jun 2013 - 457-68 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1872-9096
10.1016/j.antiviral.2013.04.008 doi
Animals
Antiviral Agents--chemistry
Benzamides--chemistry
Butadienes--chemistry
Enzyme Activation
Humans
Influenza, Human--drug therapy
Leupeptins--chemistry
MAP Kinase Signaling System
NF-kappa B--antagonists & inhibitors
Nitriles--chemistry
Orthomyxoviridae--drug effects
Phosphatidylinositol 3-Kinases--chemistry
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Virus Replication--drug effects
Development of cellular signaling pathway inhibitors as new antivirals against influenza. [electronic resource] - Antiviral research Jun 2013 - 457-68 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1872-9096
10.1016/j.antiviral.2013.04.008 doi
Animals
Antiviral Agents--chemistry
Benzamides--chemistry
Butadienes--chemistry
Enzyme Activation
Humans
Influenza, Human--drug therapy
Leupeptins--chemistry
MAP Kinase Signaling System
NF-kappa B--antagonists & inhibitors
Nitriles--chemistry
Orthomyxoviridae--drug effects
Phosphatidylinositol 3-Kinases--chemistry
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Virus Replication--drug effects